Kane Biotech was preparing the annual financial statements and, as part of the year-end procedures, assessed the assets and prepared the following alphabetized schedule based on adjusted values at December 31, 2020: (Do not round intermediate calculations. Round final answers to nearest whole dollar.)

Asset	Date of Purchase	Deprec. Method*	Cost			Residual Value			Useful Life	Accum. Deprec.			Recoverable Amount
Equipment	May 1/15	Units	$	58,000		$	5,710		8,300 units	$	33,390		$	8,710
Furniture	Jun. 28/15	DDB		25,000			3,300		8 yrs		20,819			4,650
Land	Apr. 5/15	N/A		98,000			N/A		N/A		N/A			114,800
Office building	Apr. 5/15	SL		103,000			28,700		15 yrs		34,700			65,500
Warehouse	Apr. 5/15	SL		74,500			23,000		20 yrs		25,938			58,100

*DDB = Double-declining-balance; SL = Straight-line; Units = Units-of-production; N/A = Not applicable Required: 1. Record any impairment losses at December 31, 2020. Assume Kane Biotech has recorded no impairment losses in previous years.